Hydrogen Therapy Stabilizes Heart Artery Plaques in Mouse Study
- Authors
- Guohua Song, Chuanlong Zong, Zhaoqiang Zhang, Yang Yu, Shutong Yao, Peng Jiao, Hua Tian, Lei Zhai, Hui Zhao, Shuyan Tian, Xiangjian Zhang, Yun Wu, Xuejun Sun, Shucun Qin
- Journal
- Free Radical Biology and Medicine
- Year
- 2015
- DOI
- 10.1016/j.freeradbiomed.2015.06.018
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Atherosclerosis
- Body System
- Cardiovascular
TL;DR
Hydrogen gas (H2) treatment improves the stability of artery-clogging plaques in mice, potentially reducing the risk of heart attacks.
Key Finding
Molecular hydrogen stabilized atherosclerotic plaques in mice by suppressing cellular stress responses and activating antioxidant pathways, producing effects comparable to simvastatin treatment.
Summary
Researchers tested whether molecular hydrogen (H2) could help stabilize atherosclerotic plaques—the buildup of fatty deposits in arteries that can rupture and cause heart attacks. Using genetically modified mice prone to atherosclerosis, they gave some animals hydrogen daily and compared results to untreated mice and those given simvastatin (a common cholesterol drug). Hydrogen treatment made plaques more stable by increasing protective structural components and reducing harmful inflammatory cells and oxidized cholesterol. Laboratory studies showed hydrogen worked by reducing cellular stress and harmful molecules called free radicals (reactive oxygen species).
Practical Takeaway
This early-stage animal research suggests hydrogen may help protect against plaque rupture, but these are mouse studies only and do not yet demonstrate effects in humans. Much more research, including human clinical trials, would be needed before any health claims could be made about hydrogen water and cardiovascular protection.
Abstract (excerpt)
Hydrogen (H2) attenuates the development of atherosclerosis in mouse models. We aimed to examine the effects of H2 on atherosclerotic plaque stability. Low-density lipoprotein receptor knockout (LDLR(-/-)) mice fed an atherogenic-diet were dosed daily with H2 and/or simvastatin. In vitro studies…